THE CONTENT OF THIS WEBSITE HAS NOT BEEN APPROVED.
Pegylated interferon and ribavirin is an expensive therapy. A year’s cost will be about $19,000. Few patients are able to pay for this unaided. Therefore, for most patients some form of reimbursement will be required. This will be mainly through the Ministry of Health and Long Term Care or through private insurers. A few patients will be eligible for co-payment from the manufacturers.
Ontario Drug Benefit
www.health.gov.on.ca/english/public/forms/form_menus/odb_fm.html
Ontario Drug Benefit Formulary (OBD) will reimburse most patients for hepatitis C treatment. Each patient’s application undergoes review by an expert (section 8 or Individual Clinical Review).
Ontario patients belonging to one of the following groups and who are insured by OHIP are eligible for coverage
- Trillium Drug Program recipients
The address to send applications is:
Drug Programs Branch
5700 Yonge St, 3rd Floor
Toronto, Ontario
M2M 4K5
1-866-811-9893
Fax: 416-327-8123
All private insurers will pay at least some of the costs of treatment. However, the extent of coverage varies from as little as 50% to 100%. Thus many patients will require Trillium Program assistance as well as private insurance.
These are programs established by Roche and Schering to assist patients with obtaining reimbursement for hepatitis C treatment. Both programs will help with completing the necessary forms, and negotiating with the insurance companies. Peg-care can be reached at 1-800-603-2754
PegAssist can be reached at 1-877-PEGASYS
Patients who became infected from transfusion of blood or blood products are entitled to compensation. There are two groups who qualify.
|
|
Canadian Red Cross Settlement (CRCS) |
1986-1990 Hepatitis C Settlement Agreement |
|
Description |
The settlement covers class action members across Canada who were infected with HCV through the blood system pre 86 and post 90 and were excluded from the $1.1B Federal/Provincial/Territorial 1986-1990 settlement plan. |
Legal settlement to provide compensation to those infected with HCV through the blood system between January 1, 1986 and July 1, 1990. Payments to applicants are illness based ranging from level 1 (HCV antibody positive) to level 5 (cirrhosis of the liver) |
|
Administration |
Independent third party administrator (KPMG) |
Independent third party administrator (Crawford Group) |
|
Total Funding Amount |
$63M
|
$1.1B |
|
Duration of Settlement/Agreement |
Funds are distributed on specified dates. First instalment ($6,880) June 2002, second instalment ($3,570) December 2004. Next instalment date unknown and all remaining funds distributed by December 2011. N.B This fund has recently been depleted, therefore new applicants to the program will not receive any money at this time. |
Up to 70 years or until all funds have been distributed to all eligible applicants.
|
|
Contact info |
KPMG Canada, Administrator |
1986-1990 Hepatitis C Claims Centre |
|
Program Name |
Ontario Hepatitis C Assistance Plan (OHCAP) |
|
Eligibility Criteria |
Those who were infected with HCV through the blood system in Ontario on or before December 31, 1985 and between July 2, 1990 - September 28, 1998 |
|
Amount of Financial Assistance Paid per Applicant |
Original amount was a one time payment of $10,000. This was increased to a one-time payment of $25,000 in May 2000. (All those who received the initial $10,000 received an additional $15,000) |
|
How to apply for the Program |
There are two forms that require completion. The Applicant form is completed by the applicant and provides personal information including the applicant's address and phone number. As well, the names of the doctors who are familiar with the applicant's hepatitis C infection are listed in addition to the hospital(s) where the applicant received the blood transfusion or blood product. |
|
Contact Info |
Call the Ministry of Health and
|
|
Program Sunset Date |
Not yet determined |
www.health.gov.on.ca/english/public/pub/drugs/trillium.htmlThe Trillium Drug Program (TDP) is intended for Ontario residents who have a valid Ontario Health Card and who have high prescription drug costs in relation to their net household income.
The TDP provides coverage for prescription drug products listed on the Ontario Drug Benefit Formulary/Comparative Drug Index (Formulary) as follows :
Drug products that are not listed on the Formulary are also considered for coverage for TDP recipients through the ministry's Individual Clinical Review (ICR/Section 8) mechanism on a case-by-case basis. (For more information : Ontario Drug Benefit : Section 8–Special coverage of a non-listed drug product Mechanism.)
You can register in the Trillium Drug Program if:
The program runs from August 1 to July 31 of the following year. Before you will receive coverage for eligible prescription drug products through the TDP, your household must pay for a set amount of your prescription drug purchases, otherwise known as the "deductible", each year starting August 1. The deductible is paid in four instalments over the program year and is calculated based on net household income and household size.
For example, a household with an annual deductible of $500 will pay for the first $125 of prescriptions purchased at the start of each quarter on August 1, November 1, February 1, and May 1. After the deductible is paid in each quarter, the household will be eligible to receive drug benefits for that quarter, and will be asked to pay up to $2 per prescription each time they purchase an eligible drug product. Any unpaid deductible in a quarter will be added to the next quarter's deductible.
New applicants to the TDP can choose the date within the program year on which they wish to be enrolled in the program. The deductible will be prorated, that is, the deductible will be based on the number of days left in the program year. Please note that proration of the deductible will apply only for the first year that a household/member is enrolled in the program.
Only eligible drug costs count towards your Trillium Drug Program deductible or are covered as program benefits. To ensure coverage under the program, check with your pharmacist or health care provider to make sure your prescriptions fit into one of the following categories :
Trillium application kits are available at your local pharmacy, or by calling 1-800-575-5386. The application form and application guide are also available online :
P.O. Box 337, Station D
Etobicoke, Ontario
M9A 4X3
Tel : 416-642-3038
Fax : 416-642-3034
Toll-Free : 1-800-575-5386
E-mail : trillium@resolve.com